نتایج جستجو برای: chronic myeloid leukemia

تعداد نتایج: 744967  

Mohammad Reza Rezaie, Tohid Yousefzadeh Hassanluie Zahra Rostami

Background:Leukemia is cancer of blood and bone marrow cells. In general, there are four types of leukemia: chronic myelogenous leukemia (CML), acute myeloid leukemia (AML), B-cell chronic lymphocytic leukemia (CLL) and acute lymphoblastic leukemia (ALL).  Fractal geometry can be introduced as one of the effective ways to detect this type of cancer. In this study, with introduc...

Journal: :international journal of pediatrics 0
mojtaba miladinia chronic diseases care research center, school of nursing and midwifery, ahvaz jundishapur university of medical sciences, ahvaz, i.r iran. leila fakharzadeh pediatric group, abadan faculty of nursing , abadan school of medical science university, abadan, i.r iran. kourosh zarea chronic diseases care research center, school of nursing and midwifery, ahvaz jundishapur university of medical sciences, ahvaz, i.r iran. elham mousavi nouri chronic diseases care research center, school of nursing and midwifery, ahvaz jundishapur university of medical sciences, ahvaz, i.r iran.

background among all malignances, leukemia has the greatest effects on patients 'psychological aspects. anxiety is common problem in leukemia patients (especially in children). since no study has addressed the effect of slow-stroke back massage (ssbm) on anxiety in the pediatrics with chronic leukemia, this investigation aimed to controlling anxiety through a non-drug method (such as ssbm)...

Journal: :Biomedica : revista del Instituto Nacional de Salud 2014
Martín Romero Diana Chávez Magalí De Los Ríos Nelson Alvis-Guzmán

INTRODUCTION New tyrosine kinase inhibitor treatments for chronic myeloid leukemia based on nilotinib, dasatinib and imatinib have improved patient quality of life and have turned chronic myeloid leukemia from a fatal disease into a chronic disease. OBJECTIVE To evaluate the cost-effectiveness of nilotinib, 600 mg, and dasatinib, 100 mg, each compared to imatinib, 400 mg, as first-line therap...

Journal: :Cancer research 1999
U R Peters M P Tschan K A Kreuzer G Baskaynak U Lass A Tobler M F Fey C A Schmidt

The role of the recently identified first p53-homologue, p73, in neoplastic transformation is unknown. To elucidate p73 gene expression in hematopoiesis, we investigated samples from chronic myeloid leukemia (CML) and acute myeloid leukemia patients, leukemia cell lines, as well as mature and immature normal hematopoietic cells by real-time quantitative RT-PCR and Western blot analysis. We foun...

Journal: :Blood 1977
E N Forman T Padre-Mendoza P S Smith B E Barker P Farnes

Two children presented with Ph1-positive leukemia, confirmed by Giemsa banding as 22q-. One child showed an initial presentation characteristic of acute lymphoblastic leukemia, followed by development of chronic myelocytic leukemia 2 yr later. A second child presented in blast crisis. Both patients showed blast cells possessing both lymphoid and myeloid characteristics, as demonstrated by histo...

2015
Mihaela I Precup Cornea Emmanuel Levrat Paul Pugin Daniel C Betticher

INTRODUCTION The World Health Organization classification of chronic myeloproliferative disease encompasses eight entities of bone marrow neoplasms, among them Breakpoint cluster region-Abelson murine leukemia viral oncogene homolog 1-positive chronic myeloid leukemia and polycythemia vera. Polycythemia vera requires, in the majority of cases (95%), the negativity of Breakpoint cluster region-A...

Journal: :Journal of Global Oncology 2017

Journal: :International Journal of Hematology 2018

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید